table of content
1 Introduction to Research & Analysis Reports
1.1 Radioligand Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radioligand Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radioligand Therapy Overall Market Size
2.1 Global Radioligand Therapy Market Size: 2022 VS 2035
2.2 Global Radioligand Therapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radioligand Therapy Players in Global Market
3.2 Top Global Radioligand Therapy Companies Ranked by Revenue
3.3 Global Radioligand Therapy Revenue by Companies
3.4 Top 3 and Top 5 Radioligand Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Radioligand Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radioligand Therapy Players in Global Market
3.6.1 List of Global Tier 1 Radioligand Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Radioligand Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Radioligand Therapy Market Size Markets, 2022 & 2035
4.1.2 Actinium 225 (Ac-225)
4.1.3 Lutetium 177 (Lu-177)
4.1.4 Gallium 68 (Ga-68)
4.1.5 Fluorine 18 (F-18)
4.1.6 Other Radionuclides
4.2 By Type - Global Radioligand Therapy Revenue & Forecasts
4.2.1 By Type - Global Radioligand Therapy Revenue, 2018-2023
4.2.2 By Type - Global Radioligand Therapy Revenue, 2024-2035
4.2.3 By Type - Global Radioligand Therapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radioligand Therapy Market Size, 2022 & 2035
5.1.2 Neuroendocrine Neoplasms
5.1.3 Prostate Cancer
5.2 By Application - Global Radioligand Therapy Revenue & Forecasts
5.2.1 By Application - Global Radioligand Therapy Revenue, 2018-2023
5.2.2 By Application - Global Radioligand Therapy Revenue, 2024-2035
5.2.3 By Application - Global Radioligand Therapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Radioligand Therapy Market Size, 2022 & 2035
6.2 By Region - Global Radioligand Therapy Revenue & Forecasts
6.2.1 By Region - Global Radioligand Therapy Revenue, 2018-2023
6.2.2 By Region - Global Radioligand Therapy Revenue, 2024-2035
6.2.3 By Region - Global Radioligand Therapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Radioligand Therapy Revenue, 2018-2035
6.3.2 US Radioligand Therapy Market Size, 2018-2035
6.3.3 Canada Radioligand Therapy Market Size, 2018-2035
6.3.4 Mexico Radioligand Therapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Radioligand Therapy Revenue, 2018-2035
6.4.2 Germany Radioligand Therapy Market Size, 2018-2035
6.4.3 France Radioligand Therapy Market Size, 2018-2035
6.4.4 U.K. Radioligand Therapy Market Size, 2018-2035
6.4.5 Italy Radioligand Therapy Market Size, 2018-2035
6.4.6 Russia Radioligand Therapy Market Size, 2018-2035
6.4.7 Nordic Countries Radioligand Therapy Market Size, 2018-2035
6.4.8 Benelux Radioligand Therapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Radioligand Therapy Revenue, 2018-2035
6.5.2 China Radioligand Therapy Market Size, 2018-2035
6.5.3 Japan Radioligand Therapy Market Size, 2018-2035
6.5.4 South Korea Radioligand Therapy Market Size, 2018-2035
6.5.5 Southeast Asia Radioligand Therapy Market Size, 2018-2035
6.5.6 India Radioligand Therapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Radioligand Therapy Revenue, 2018-2035
6.6.2 Brazil Radioligand Therapy Market Size, 2018-2035
6.6.3 Argentina Radioligand Therapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radioligand Therapy Revenue, 2018-2035
6.7.2 Turkey Radioligand Therapy Market Size, 2018-2035
6.7.3 Israel Radioligand Therapy Market Size, 2018-2035
6.7.4 Saudi Arabia Radioligand Therapy Market Size, 2018-2035
6.7.5 UAE Radioligand Therapy Market Size, 2018-2035
7 Radioligand Therapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Radioligand Therapy Major Product Offerings
7.1.4 Novartis Radioligand Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Advanced Accelerator Applications
7.2.1 Advanced Accelerator Applications Company Summary
7.2.2 Advanced Accelerator Applications Business Overview
7.2.3 Advanced Accelerator Applications Radioligand Therapy Major Product Offerings
7.2.4 Advanced Accelerator Applications Radioligand Therapy Revenue in Global Market (2018-2023)
7.2.5 Advanced Accelerator Applications Key News & Latest Developments
7.3 Mercy Radiology
7.3.1 Mercy Radiology Company Summary
7.3.2 Mercy Radiology Business Overview
7.3.3 Mercy Radiology Radioligand Therapy Major Product Offerings
7.3.4 Mercy Radiology Radioligand Therapy Revenue in Global Market (2018-2023)
7.3.5 Mercy Radiology Key News & Latest Developments
7.4 POINT Biopharma Global Inc
7.4.1 POINT Biopharma Global Inc Company Summary
7.4.2 POINT Biopharma Global Inc Business Overview
7.4.3 POINT Biopharma Global Inc Radioligand Therapy Major Product Offerings
7.4.4 POINT Biopharma Global Inc Radioligand Therapy Revenue in Global Market (2018-2023)
7.4.5 POINT Biopharma Global Inc Key News & Latest Developments
7.5 Fusion Pharma
7.5.1 Fusion Pharma Company Summary
7.5.2 Fusion Pharma Business Overview
7.5.3 Fusion Pharma Radioligand Therapy Major Product Offerings
7.5.4 Fusion Pharma Radioligand Therapy Revenue in Global Market (2018-2023)
7.5.5 Fusion Pharma Key News & Latest Developments
7.6 Telix Pharmaceuticals Ltd
7.6.1 Telix Pharmaceuticals Ltd Company Summary
7.6.2 Telix Pharmaceuticals Ltd Business Overview
7.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Major Product Offerings
7.6.4 Telix Pharmaceuticals Ltd Radioligand Therapy Revenue in Global Market (2018-2023)
7.6.5 Telix Pharmaceuticals Ltd Key News & Latest Developments
7.7 Lantheus Holdings, Inc
7.7.1 Lantheus Holdings, Inc Company Summary
7.7.2 Lantheus Holdings, Inc Business Overview
7.7.3 Lantheus Holdings, Inc Radioligand Therapy Major Product Offerings
7.7.4 Lantheus Holdings, Inc Radioligand Therapy Revenue in Global Market (2018-2023)
7.7.5 Lantheus Holdings, Inc Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Company Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Radioligand Therapy Major Product Offerings
7.8.4 Bayer AG Radioligand Therapy Revenue in Global Market (2018-2023)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Curium Pharma
7.9.1 Curium Pharma Company Summary
7.9.2 Curium Pharma Business Overview
7.9.3 Curium Pharma Radioligand Therapy Major Product Offerings
7.9.4 Curium Pharma Radioligand Therapy Revenue in Global Market (2018-2023)
7.9.5 Curium Pharma Key News & Latest Developments
7.10 Precirix
7.10.1 Precirix Company Summary
7.10.2 Precirix Business Overview
7.10.3 Precirix Radioligand Therapy Major Product Offerings
7.10.4 Precirix Radioligand Therapy Revenue in Global Market (2018-2023)
7.10.5 Precirix Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
